Top Markets
Coin of the day
MicroPort NeuroTech Limited MicroPort NeuroTech Limited

MicroPort NeuroTech Limited

2172
Clasificación en acciones #11874
Established in 2004 and headquartered in Shanghai, People's Republic of China,... Established in 2004 and headquartered in Shanghai, People's Republic of China, MicroPort NeuroTech Limited is dedicated to the research, development, manufacturing, and global commercialization of neuro-interventional medical devices. The company's diverse product portfolio addresses various cerebrovascular conditions. For treating hemorrhagic stroke, it offers the NUMEN coil embolization system, the NUMEN FR coil detachment system, the Tubridge flow-diverting stent, the Willis intracranial stent graft system, and the Rebridge intracranial visualized stent. Additionally, MicroPort NeuroTech supplies the APOLLO intracranial arterial stent system for intracranial atherosclerotic disease, as well as the Bridge rapamycin target eluting vertebral artery stent system specifically designed for cerebral atherosclerotic stenosis. To address acute ischemic stroke, the company provides the Neurohawk stent thrombectomy device and the Tigertriever adjustable stent retriever.
Precio por acción
$1.04
Capitalización bursátil
$603.62M
Cambio (1 día)
-2.52%
Cambio (1 año)
-38.05%
País
CN
Comercio MicroPort NeuroTech Limited (2172)

Categoría

Ganancias de MicroPort NeuroTech Limited (2172)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di MicroPort NeuroTech Limited, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de MicroPort NeuroTech Limited desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
$7.51B -
US
$5.15B -
US
$5.56B -
IE
$3.86B -
US
- -
DE